In turn, disruption of the Golgi complex in the brain (e.g., by targeted deletion of GM130 in mouse) led to the phenotypic triad also observed in SCAs, i.e., Purkinje cell loss, cerebellar atrophy and ataxia (Liu et al. 2017). The gene discussed is GOLGA2; the disease is cerebellar ataxia.